Torrent Pharma gets UK’s MHRA nod to sell the generic version of Abilify tablets

17 Nov 2015 Evaluate

Torrent Pharmaceuticals has received approval from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) to sell the generic version of Abilify tablets, used in treatment of mental disorders.

While the drug is primarily used in the treatment of schizophrenia and bipolar disorder, it is also used as an add-on treatment in major depressive disorder, tic disorders and irritability associated with autism.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3757.95 -23.60 (-0.62%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×